Tamoxifen (TAM), the antiestrogenic drug most widely prescribed in the chemotherapy of breast cancer, induces changes in normal discoid shape of erythrocytes and hemolytic anemia. This work evaluates the effects of TAM on isolated human erythrocytes, attempting to identify the underlying mechanisms on TAM-induced hemolytic anemia and the involvement of biomembranes in its cytostatic action mechanisms. TAM induces hemolysis of erythrocytes as a function of concentration. The extension of hemolysis is variable with erythrocyte samples, but 12.5 WM TAM induces total hemolysis of all tested suspensions. Despite inducing extensive erythrocyte lysis, TAM does not shift the osmotic fragility curves of erythrocytes. The hemolytic effect of TAM is prevented by low concentrations of K-tocopherol (K-T) and K-tocopherol acetate (K-TAc) (inactivated functional hydroxyl) indicating that TAM-induced hemolysis is not related to oxidative membrane damage. This was further evidenced by absence of oxygen consumption and hemoglobin oxidation both determined in parallel with TAMinduced hemolysis. Furthermore, it was observed that TAM inhibits the peroxidation of human erythrocytes induced by AAPH, thus ruling out TAM-induced cell oxidative stress. Hemolysis caused by TAM was not preceded by the leakage of K from the cells, also excluding a colloid-osmotic type mechanism of hemolysis, according to the effects on osmotic fragility curves. However, TAM induces release of peripheral proteins of membrane-cytoskeleton and cytosol proteins essentially bound to band 3. Either K-T or K-TAc increases membrane packing and prevents TAM partition into model membranes. These effects suggest that the protection from hemolysis by tocopherols is related to a decreased TAM incorporation in condensed membranes and the structural damage of the erythrocyte membrane is consequently avoided. Therefore, TAMinduced hemolysis results from a structural perturbation of red cell membrane, leading to changes in the framework of the erythrocyte membrane and its cytoskeleton caused by its high partition in the membrane. These defects explain the abnormal erythrocyte shape and decreased mechanical stability promoted by TAM, resulting in hemolytic anemia. Additionally, since membrane leakage is a final stage of cytotoxicity, the disruption of the structural characteristics of biomembranes by TAM may contribute to the multiple mechanisms of its anticancer action. ß
Introduction
Tamoxifen (TAM) is a synthetic non-steroidal antiestrogen widely used in the chemotherapy of breast cancer [1] . The established e¤ciency and low incidence of side e¡ects allowed the use of TAM as a chemopreventive drug [2] . Recently, it was reported that TAM induces multiple cellular adverse e¡ects, including changes in normal discoid shape of erythrocytes with formation of stomatocytes, meaning that the drug may insert in the inner lea£et of the erythrocyte membrane [3] . Additionally, it has been suggested that TAM causes hemolytic anemia [4, 5] , but the biochemical mechanisms were not identi¢ed.
The antiproliferative e¡ects of TAM and other triphenylethylene derivatives in estrogen-dependent breast cancer cells are believed to be mediated by high a¤nity binding to the estrogen receptor (ER), thereby blocking the growth stimulating action of estradiol [6] . However, TAM also inhibits the growth of ER-negative breast cancer cells and other cell types which lack ER [7^10]. Furthermore, in some ER-positive and ER-negative cell lines, the antiproliferative e¡ect of TAM is not overcome by estrogen addition [8, 11] . Moreover, the mechanisms underlying the ER-independent inhibition of tumor cell growth by TAM also remain obscure. Thus, extensive studies have been performed and multiple cellular e¡ects have been described, namely, binding to antiestrogen binding sites [12, 13] , inhibition of protein kinase C [14, 15] , inhibition of a nucleoside transporter protein [16] , inhibition of cAMP phosphodiesterase [17, 18] , antagonism of calmodulin by a direct interaction with this protein [19] and induction of apoptosis [20, 21] .
Biomembranes, where TAM strongly incorporates [22] interacting with lipids [23] and proteins [19, 24] , have been suggested as a potential target for TAM action [25] . Indeed, TAM induces early modi¢ca-tions in the morphology and structure of breast tumor cell membranes putatively related with its antiproliferative activity [26] . Moreover, TAM has been reported to disrupt unspeci¢cally the structure of model membranes [24, 27] and the permeabilization of the mitochondria and the parallel loss of membrane potential induced by TAM has been assigned to a structural disruption of the mitochondrial membrane [28] .
At present, e¡ects of TAM on erythrocyte membrane integrity have not been reported. On the other hand, it has been ascertained that free radical-mediated peroxidation of erythrocyte membrane lipids and proteins and changes in cytoskeleton proteins eventually promote hemolysis. Therefore, the reports of hemolytic anemia caused by TAM alone [4] or in combination with mitomycin C, not related to bone marrow toxicity [5] , prompted us to search the e¡ects of TAM on isolated human erythrocytes, particularly on the potential oxidative disruption and physical damage of cell membrane and the protection afforded by antioxidants or membrane stabilizers, e.g. K-tocopherol (K-T) and K-tocopherol acetate (KTAc). Thus, the aim of these studies was to contribute for the elucidation of the underlying mechanisms of TAM-induced hemolytic anemia and to clarify the role of biomembranes in its cytostatic action mechanisms.
Materials and methods

Chemicals
Tamoxifen, 1,6-diphenyl-1,3,5-hexatriene (DPH), HEPES, acrylamide, Coomassie brilliant blue R-250, K-tocopherol acetate (K-TAc) and protein markers for molecular weight were obtained from Sigma (St. Louis, MO, USA). 9,11,13,15-Octadecatetraenoic acid (cis-parinaric acid) (PnA) and 3-[p-(6-phenyl)-1,3,5-hexatrienil]-phenylpropionic acid (DPH-PA) were from Molecular Probes (Junction City, OR). 2,2P-Azobis(2-amidinopropane)dihydrochloride (AAPH) was obtained from Polysciences (Warrington, PA). K-Tocopherol (K-T) was purchased from Fluka, Switzerland. Bisacrylamide, TEMED, ammonium persulfate and glycine were from Merck (Darmstadt). All the other chemicals were of research grade. Solutions were prepared in deionized ultra pure water.
Preparation of erythrocyte suspensions
Freshly collected human blood, obtained from 12 healthy donors (25^50 years old and not submitted to any drug treatment) who are working in our laboratory, was mixed with heparin and centrifuged at 3000 rpm/10 min to separate plasma and erythrocytes. The retrieved erythrocytes were washed three times with 6 vols. of the isotonic phosphate bu¡ered saline (PBS) (150 mM NaCl, 10 mM sodium phosphate, pH 7.4). The bu¡y coat was carefully removed with each wash. After the last washing, the packed cells were re-suspended in PBS and the hematocrit determined. The erythrocyte suspensions used in experiments were prepared daily.
Osmotic fragility and hemolysis measurements
The osmotic fragility assays were performed in phosphate bu¡er solutions (10 mM sodium phosphate, pH 7.4) containing increasing concentrations of NaCl and hematocrit of 0.33%. The hemolysis experiments were carried out in erythrocyte suspensions (4 ml) in PBS with hematocrit of 0.33%. The protective e¡ects of K-T and K-TAc were assessed by preincubating the erythrocyte suspensions with these tocopherols at 37³C/2 h before TAM addition. In a set of samples, the erythrocytes preincubated with K-T and K-TAc were washed three times with 10 ml of PBS before the addition of TAM.
TAM was added from a stock ethanolic solution (2^4 Wl) and incubated with erythrocyte suspensions at 37³C for 1 h in a shaking water bath with gentle magnetic stirring. After incubation, the erythrocyte suspensions were centrifuged at 3000 rpm/10 min and hemolysis was estimated from the 540 nm absorbance of hemoglobin released into the supernatant. The results were expressed as % hemolysis. Zero hemolysis was taken as the absorbance of the supernatant of erythrocyte suspensions in isotonic phosphate bu¡er in the absence of TAM and 100% hemolysis was assigned when bu¡er was replaced by water, containing an identical volume of ethanol to that used in the experiments with TAM.
The e¥ux of K from the erythrocyte suspensions was measured with a K ion-selective electrode made in our laboratory, as described elsewhere [29] . The total amount of K was determined by the addition of 0.5% Triton X-100 to the erythrocyte suspensions.
The recordings are typical assays or represent the mean þ S.D. of three independent experiments.
Evaluation of oxidative stress in erythrocytes
The putative peroxidation occurring during hemolysis induced by 12.5 WM TAM and the peroxidative degradation of the lysate induced by 20 mM AAPH were followed by O 2 consumption and by changes in the hemoglobin absorption spectrum.
The rate of O 2 consumption was monitored using a Clark-type oxygen electrode (YSI model 5331, Yellow Spring Institute) as previously described [30] . The reactions were carried out in a closed glass vessel thermostated at 37³C, provided with magnetic stirring and the hemolysis of erythrocyte suspension (0.33% hematocrit) was induced by addition of 12.5 WM TAM. After 60 min of TAM addition, the azoinitiator AAPH (20 mM) was added and O 2 consumption was followed for another period of 60 min. Oxygen consumption was calculated assuming an O 2 concentration of 177 nmol/ml at 37³C.
During the incubation of erythrocyte suspensions with 12.5 WM TAM and also after addition of 20 mM AAPH, aliquots of the suspension were taken up, centrifuged at 3000 rpm/5 min and the hemoglobin spectrum was analyzed in the supernatant. Withdrawn aliquots were chilled before centrifugation to stop the thermal decomposition reaction of the azoinitiator. Hemoglobin oxidation was followed by the decay of the absorption spectrum at 450^650 nm using a Perkin-Elmer Lambda 6 UV/VIS spectrophotometer (Norwalk, USA).
The oxidation of 1.5 WM PnA incorporated in the membrane of intact erythrocytes (0.05% hematocrit) was induced by 1 mM AAPH at 37³C. TAM (10 WM) was preincubated with the erythrocyte suspension at 37³C/2 min before addition of PnA. After 90 s of recording the basal signal, PnA was added and £uo-rescence intensity was monitored using a PerkinElmer LS-50 spectro£uorimeter provided with thermostated cuvettes and magnetic stirring. The excitation was set at 312 nm and the emission at 450 nm. The excitation and emission slit widths were 5 and 15 nm, respectively. Experiments of spontaneous £uorescence decay of PnA (blank) and in the absence of drug (control) were performed. The experimental conditions used were previously established to ascertain that the £uorescence intensity of incorporated PnA is linear with its concentration and that the hematocrit is high enough to incorporate most of the probe. The excitation and emission conditions used minimize the £uorescence quenching promoted by hemoglobin.
Partition coe¤cient and £uorescence polarization
The partition coe¤cient (K p ) of TAM was determined by means of second derivative UV spectrophotometry, enabling the quanti¢cation of the drug in the lipid phase as previously described [22] . DMPC liposomes and liposomes containing K-T or K-TAc were prepared, after solvent evaporation to dryness, by dispersion in 50 mM NaCl, 10 mM HEPES, pH 7.4. The lipid suspensions were obtained as described elsewhere [22] , except that liposomes were vortexed and sonicated during four bursts of 2 min and left to equilibrate overnight at 4³C before use.
The £uorescent probes of membrane £uidity DPH and DPH-PA were incorporated at 37³C/3 h into DMPC liposomes (345 WM in phospholipid) as described elsewhere [23] . Liposomes without or containing K-T and K-TAc were prepared as described above by dispersion in 50 mM KCl and 10 mM Trismaleate, pH 7 [31] . The lipid/probe molar ratio was about 400. The £uorimetric measurements were carried out in a Perkin-Elmer LS-50 spectro£uorimeter (Beacons¢eld, UK) and the excitation was set at 336 nm and the emission at 450 nm, being the band widths 3 and 4 nm, respectively. The degree of £uo-rescence polarization (P) was determined as reported elsewhere [32] . Adequate control experiments were carried out without added probes to correct for the contribution of light scattering.
TAM was incubated with liposomes at 37³C for 20 min before K p and P measurements. The values are the mean of three independent experiments.
SDS-polyacrylamide gel electrophoresis
SDS-polyacrylamide slab gels were prepared according to the procedure of Laemmli [33] . The slab gel consisted of a 5% polyacrylamide stacking gel and a 10% polyacrylamide separating gel.
Ghost membranes were prepared from erythrocyte suspensions lysed at 37³C/1 h in absence (control) and presence of 12.5 WM TAM and centrifuged at 15 000 rpm/20 min. Hemolysis in control assay was carried out in hypotonic bu¡er. In either case, the erythrocyte membranes were washed twice with 20 ml of hypotonic phosphate bu¡er and centrifuged at 19 000 rpm/20 min. The protein of ghosts re-suspended in PBS was estimated by the biuret method [34] in the presence of SDS, using bovine serum albumin as standard and adjusted at 1.5 mg/ml. Slab gels were stained with Coomassie brilliant blue R-250 and destained with a mixture of 25% methanol and 5% acetic acid.
Results and discussion
TAM e¡ects on osmotic fragility and hemolysis of human erythrocytes
The interactions of TAM with biomembranes have been reported to contribute to its multiple cellular e¡ects [23, 24, 27] . Recently, we suggested that mitochondrial swelling and membrane potential depolarization induced by TAM re£ect a direct action of this drug on the inner membrane structure [28] . There- Fig. 1 . E¡ect of TAM on the osmotic fragility of human erythrocytes. Erythrocyte suspensions (0.33% hematocrit) in 10 mM phosphate bu¡er containing increasing concentrations of NaCl were incubated at 37³C/1 h in the absence (control) (a) and in the presence of 7.5 WM TAM (b). Hemolysis was calculated from the 540 nm absorbance of the supernatant after centrifugation of the erythrocyte suspensions and the results expressed as percentage of total hemolysis. fore, to con¢rm the potential relationship between hemolytic anemia and membrane structural defects induced by TAM, the e¡ects of this drug on the osmotic fragility and hemolysis of human erythrocytes were studied.
The e¡ects of TAM on the osmotic fragility, evaluated from the curves of hemolysis as a function of NaCl concentration, are shown in Fig. 1 . Incubation of 7.5 WM TAM with the erythrocyte suspensions induces a maximum of 20% hemolysis in the isotonic range. However, TAM does not shift the osmotic fragility curve as compared to erythrocytes incubated in the absence of drug (control), indicating that TAM does not modify the susceptibility of erythrocytes to hypotonic osmotic lysis. Therefore, the hemolytic e¡ect of TAM observed in the isotonic range is not assigned to changes in osmotic membrane permeability, in agreement to K e¥ux data monitored in parallel to hemoglobin release (Fig. 2) . As shown in this ¢gure, the K leakage curve resulting from the incubation of erythrocyte suspensions with 10 WM TAM at 37³C is very close to the hemolysis curve. The similar rates of K and hemoglobin release strongly exclude the lateralization or redistribution of transmembrane proteins into clusters or aggregates induced by TAM, leading to the formation of pores and consequent colloid-osmotic lysis, a mechanism that has been well characterized over the last decade for potent membranolytic agents [35] . Rather, the results support the concept of TAM-induced hemolysis occurring via direct membrane disruption.
The hemolysis induced by TAM on erythrocytes suspended in isotonic medium (PBS) was studied as a function of incubation time and drug concentration in several erythrocyte suspensions obtained from different donors (Fig. 3, lines 1^4 ). As shown in Fig.  3A , incubation of red cells with 10 WM TAM at 37³C results in a time-dependent hemolysis and, although the extension of hemolytic e¡ect depends on blood donor, it reaches a maximum after 1 h of incubation with the drug for all the samples. The hemolysis extension induced by TAM is slower for old subjects (more than 40 years old) (Fig. 3A, lines 3^4) , according to other studies pointing that the sensitivity to hemolysis decreases as a function of age while the membrane cholesterol content, that strongly decreases TAM partitioning in biomembranes [22] , increases with age. The hemolysis is drug concentration-dependent and complete hemolysis occurs at 12.5 WM TAM incubated at 37³C for 1 h (Fig. 3B) , independently of the erythrocyte donor.
It has been reported that TAM partitions strongly in biomembranes [22] and that in humans the levels of TAM are 10^60-fold higher in tissues than in serum (1 WM) [36] . Thus, at high concentrations in vivo, probably the excessive incorporation of TAM may disrupt the erythrocyte membrane and cause extensive hemolysis. Indeed, TAM-induced hemolytic anemia observed in patients under TAM therapy might be consequence of a direct e¡ect on erythrocyte membrane, resulting in the disruption of membrane structure.
To ascertain the potential mechanisms of TAMinduced erythrocyte hemolysis, as putative oxidative disruption and physical perturbation, the e¡ects of antioxidants and membrane stabilizers, e.g. K-T and K-TAc, were studied. The hemolytic e¡ect of TAM is inhibited by low concentrations of K-T previously incorporated into erythrocytes (Fig. 4A) . When erythrocytes were washed after preincubation with K-T, the protection against TAM-induced hemolysis is maintained and K-T exhibits nearly the same inhibitory e¡ects as in unwashed erythrocytes. K-T is more e¡ective in suppressing hemolysis than K-TAc since 2 WM K-T inhibits about 80% hemolysis (Fig. 4A ) and the same e¡ect is observed only at 15 WM K-TAc (Fig. 4B) . After washing of erythrocytes to rule out any interference by free K-TAc, small di¡erences are observed on K-TAc protective e¡ects as compared to unwashed erythrocytes, except for concentrations below 5 WM K-TAc. These observations indicate that K-T, with a selective uptake system in red blood cells [37] , and K-TAc incorporate deeply into the erythrocyte membrane and are not signi¢cantly released by washing. Therefore, the protective e¡ects of tocopherols against TAM-induced hemolysis probably result from interaction of tocopherols in the membrane core, excluding any surface action. Hence, the hydroxyl group of K-T is not critical for protection of membrane against TAM-induced damage, but rather the chroman ring, according to the e¡ects described elsewhere for inhibition of retinol-induced hemolysis [38] .
K-T is a widespread naturally occurring compound that acts as the major lipophilic antioxidant in biological systems because of its ability to interrupt the peroxidative process [39] . Moreover, this compound has been shown to inhibit lipid peroxidation in human erythrocyte membranes [40] and to prevent hemolysis induced by oxygen free radicals [41] . Since K-T e¤ciently inhibits the hemolytic e¡ect of TAM, the oxidative damage of erythrocytes could in principle be involved in TAM-induced hemolysis. However, TAM is a potent intramembranous inhibitor of lipid peroxidation in model membranes, acting as a peroxyl radical scavenger [30] , and an e¤cient inhibitor of DNA oxidation [42] . Additionally, K-TAc, with the hydroxyl group blocked and hindered of antioxidant activity, also inhibits this hemolytic e¡ect, probably as a consequence of membrane structure stabilization. A major e¡ect of tocopherols is, however, related with withdrawal of TAM from incorporating in the membrane since the partition coe¤cient is strongly decreased by the tocopherol incorporation occurring at similar putative domains across the membrane structure. Therefore, these observations might suggest that TAM-induced hemolysis is not assigned to an oxidative disruption of the erythrocyte membrane.
TAM e¡ects on peroxidative degradation of erythrocytes
To further clarify the possible involvement of free radicals in the hemolytic e¡ect of TAM, oxygen consumption and hemoglobin oxidation were monitored in parallel during the time course of hemolysis induced by the drug. As observed in Fig. 5A , the hemolysis induced by 12.5 WM TAM is not accompanied by O 2 consumption or changes in the spectra of the hemoglobin released to the supernatant (Fig. 5B) . In contrast, when the generator of peroxyl radicals AAPH is added to the incubation medium, an abrupt O 2 consumption is initiated (Fig. 5A ) and a gradual conversion of the typical spectra of oxyhemoglobin into that of Met-hemoglobin is observed (Fig. 5C) , suggesting an extensive peroxidation of lipids and proteins induced by the radicals generated by AAPH. Clearly, TAM is totally silent regarding oxi- Fig. 5 . Rate of oxygen consumption associated with hemolysis of erythrocytes induced by 12.5 WM TAM and by 20 mM AAPH (A) and spectra of hemoglobin after addition of TAM (B) and AAPH (C). Erythrocyte suspensions in 150 mM NaCl, 10 mM sodium phosphate, pH 7.4 (0.33% hematocrit) were incubated with TAM and AAPH at 37³C. O 2 consumption (A) and hemoglobin spectra were monitored simultaneously during incubation of TAM for 1 h (B) and after AAPH addition (C), as described in Section 2. Hemoglobin spectra were recorded at di¡erent reaction times indicated by the numbers adjacent to the traces. Upward and downward arrows indicate an increase or decrease in absorbance due to hemoglobin release (B) and hemoglobin oxidation by AAPH added 1 h after TAM (C). dative challenge of erythrocytes as compared to AAPH.
To emphasize this observation, the e¡ect of TAM on the peroxidative process induced by AAPH in intact erythrocytes was studied by the £uorescence intensity decay of PnA. As can be observed (Fig.  6 ), the addition of AAPH to erythrocyte suspension in the absence of TAM (control) induces a decrease in PnA £uorescence relative to the spontaneous £uo-rescence decay of PnA (blank), which is related to the rate of its oxidative degradation [30] . Preincubation of TAM with erythrocytes decreases the rate of £uorescence intensity decay of PnA as compared to the control, indicating an e¤cient antioxidant activity of TAM in the ¢rst stages of erythrocyte membrane lipid peroxidation. Identical antioxidant e¡ect of TAM is also noticed in the hemolysate peroxidation induced by AAPH as evaluated by O 2 consumption (Fig. 7) . Exposing the hemolysate to AAPH-derived radicals results in lipid peroxyl radical production due to peroxidation as indicated by an increased rate of O 2 consumption as compared to experiments in the absence of erythrocytes (Fig. 7) . The preincubation of TAM with the hemolysate leads to a signi¢cant concentration-dependent decrease in the rate of O 2 uptake pointing to a strong scavenger capacity of TAM for lipid peroxyl radicals generated by AAPH as previously described [30] . However, the oxidation of oxyhemoglobin to Methemoglobin in the hemolysate induced by AAPH (Fig. 8A) is not protected by the presence of TAM (Fig. 8B) as detected by the hemoglobin spectra recorded in parallel to O 2 consumption. This inability of TAM to scavenge peroxyl radicals in aqueous phase, occurring identical hemoglobin oxidation induced by AAPH in the absence (Fig. 8A) and presence of TAM (Fig. 8B) , strongly corroborates the intramembranous scavenger properties of TAM in model membranes previously described [30] . Therefore, these results indicate that TAM induced-hemolysis is not associated to an increase in erythrocyte membrane lipoperoxidation or hemoglobin oxidative degradation induced by the drug. However, they do not exclude the possibility that TAMinduced hemolysis may result from modi¢cations on erythrocyte membrane proteins and changes on the framework of cytoskeleton and/or plasma membrane proteins.
Previous studies have suggested that membrane proteins are primary targets in cytolysis [43] . Thus, the possibility that TAM-induced hemolysis may occur from interaction with erythrocyte membrane proteins was examined by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). This methodology, allowing polypeptide separation as a function of its molecular weight, has been used to study alterations of erythrocyte membrane proteins [44, 45] , e.g. protein fragmentation and/or polymerization indicated by new bands of lower or higher molecular weight, respectively [40, 45] . Fig. 9 shows the electrophoretic pro¢le of the erythrocyte membrane proteins isolated from erythrocyte suspensions hemolysed in hypotonic bu¡er (control) and after hemolysis with 12.5 WM TAM incubated at 37³C/1 h (TAM). It is clear that TAM did not promote the appearance of new bands of higher or lower molecular weight as compared to the banding pattern of control, suggesting that TAM does not induce polymerization or fragmentation of membrane proteins. Additionally, the relative amounts of spectrin (K and L), bands 3, 4.1, 4.2 and 5 are similar in the absence (control) and presence of 12.5 WM TAM (TAM), indicating minimal changes of these proteins due to hemolysis induced by TAM. However, erythrocytes incubated with the drug display considerable changes in the intensity of some proteins bound to band 3 in the erythrocyte membrane.
The band 3 protein constitutes the anion channel that enables bicarbonate to be changed for chloride and is a binding structure for proteins of the cytoskeleton and cytosol. Recent studies showed that band 4.1 [46] , ankyrin, glycolytic enzymes, aldolase and glyceraldehyde-3-phosphate dehydrogenase (band 6), and hemoglobin [47] bind predominantly, if not exclusively, to the band 3 tetramer. TAM decreases the intensity of bands 6, 7 and 16 kDa (hemoglobin monomer), inducing changes on cytoskeleton^membrane connections and lipid bilayer. The release or solubilization of some membrane proteins suggest that TAM changes lipid^protein interactions in the bilayer and the framework of erythrocyte cytoskeleton proteins and plasma membrane. According to the e¡ects in other membrane systems [24] , where TAM strongly partitions [22] and induces changes in the bilayer geometry [23] , binding unspeci¢cally and interacting with several and distinct membrane proteins [14, 19, 48] , the hemolytic action of TAM putatively results from perturbation of erythrocyte membrane integrity and structure, by impairing lipid^lipid, lipid^protein and protein^protein interactions. Additionally, the release of hemoglobin bound to the membrane could explain the extra absorbance observed in the supernatant of erythrocytes incubated with TAM as compared to the total hemolysis (Fig. 3B) , also meaning that TAM disrupts the binding of cytosol and cytoskeleton proteins to Fig. 9 . SDS-PAGE of erythrocyte membrane proteins isolated from 0.33% erythrocyte suspensions preincubated at 37³C/1 h in the absence (Control) and in the presence of 12.5 WM TAM (TAM). Following the preincubation, membranes were separated and washed as described in Section 2. Samples containing 30 Wg protein were applied and the peptides were separated by the method of Laemmli [33] . Nomenclature of the bands is given according to the classi¢cation of Fairbanks et al. [55] and using the molecular relative weight (Mr) of markers used as standards (Std). The gel shown is representative of three similar separations. Arrowheads indicate the di¡erences in the protein banding pattern between control and TAM. band 3, the red cell most abundant intrinsic protein.
These defects induced by TAM may contribute to abnormal erythrocyte shape and diminished mechanical stability, resulting in hemolytic anemia.
E¡ect of K-T and K-TAc on K p of TAM and membrane £uidity
Owing to its lipophilic character, TAM strongly incorporates in membrane systems and its partition is modulated by several factors, e.g. £uidity degree and membrane composition, being higher in membranes containing protein and low cholesterol concentration [22] . This steroid prevents TAM incorporation, probably due to its known e¡ects on increasing lipid packing and surface density of the bilayer. Furthermore, cholesterol may compete for the microdomains where TAM incorporates, therefore displacing the drug from the membrane [22] .
Similarly to cholesterol, K-T and K-TAc, which are membrane stabilizers and condensing agents [49] are expected to a¡ect the partition coe¤cient (K p ) of TAM, decreasing its hemolytic action. Therefore, the K p of TAM was estimated as a function of K-T and K-TAc content in membrane model of DMPC multilamellar liposomes, as summarized in Fig. 10 . These studies were carried out in liposomes of synthetic lipids to minimize the very strong light scattering of suspensions and interferences in UV spectra when ghosts and erythrocytes are used [22] not allowing reliable collection of spectra data. Partitioning of TAM into DMPC liposomes in the liquidcrystalline phase remarkably decreases with K-T and K-TAc incorporation (Fig. 10) , although a stronger e¡ect is exhibited by K-T comparatively to KTAc.
To further clarify the decrease of TAM K p upon K-T or K-TAc incorporation in DMPC liposomes, the e¡ects of these compounds on the £uidity of the same membrane model were investigated by £uo-rescence polarization. To probe the inner and the outer regions of the bilayer two £uorophores were Fig. 11 . Fluorescence polarization (P) of DPH (A) and DPH-PA (B) in DMPC multilamellar liposomes (345 WM) enriched with increasing concentrations of K-T (b) and K-TAc (a) at 37³C. The molar ratio of lipid/probe was about 400 and the degree of P was determined at 336 nm excitation and 450 nm emission using 3 nm excitation and 4 nm emission bandwidths. The increase in P is indicative of structural condensation in the regions probed by the £uorophores. Data are means of three di¡erent experiments. used, DPH preferentially located in the hydrophobic core of the membrane and DPH-PA that distributes close to the interfacial region, probing the outer bilayer regions [50, 51] . Fig. 11 displays the e¡ects of K-T and K-TAc on the £uidity of DMPC membranes, as evaluated by the £uorescence polarization of DPH (Fig. 11A) and DPH-PA (Fig. 11B) . K-T increases the polarization of the £uorophores, meaning an increase in the structural order of lipids across all the thickness of the bilayer [52] . K-TAc slightly increases the polarization of DPH, but not of DPH-PA. This e¡ect of K-TAc is in agreement with its high hydrophobic character and its location predominantly in the central regions of the bilayer [53] , apart from the cooperativity region that determines the structural order. A correlation can be established between the extent of K-T and K-TAc e¡ects on TAM K p and on membrane £uid-ity, similarly to that described elsewhere for cholesterol [22] . Therefore, the inhibition of TAM-induced hemolysis by K-T and K-TAc may be due to a stabilization of the erythrocyte membrane, decreasing the incorporation of TAM and preventing the physical damage of the erythrocyte membrane resulting from TAM accumulation.
In conclusion, the results described, together with previous data [24, 28, 54] , point to a prominent role of TAM in inducing defects in erythrocyte membrane structure, leading to changes in normal erythrocyte shape and decreased mechanical stability, resulting in hemolytic anemia. Hence, the inhibition of TAM-induced hemolysis by K-T and K-TAc can be regarded as a potential preventive procedure against toxic effects exerted by this anticancer drug in normal tissues. Since cell leakage is a ¢nal stage of cytotoxicity, the disruption of the structural characteristics of biomembranes by TAM may also contribute for its multiple mechanisms of anticancer action not related to the estrogen receptors.
